Levothyroxine Sodium Tablet
Product Images NDC 51655-723

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 723 52 Master Bottle Label Approval Rev A 06 21)

Label for Levothyroxine Sodium Tablets USP 50 mcg, oral tablets, 30 count. The label states prescription use (Rx Only) and includes storage instructions to keep the product at 20°-25°C with permitted excursions and to protect from moisture and light. The label indicates repackaging by Northwind Pharmaceuticals, with original packaging from Alvogen, Inc.*

FDA Label Image

Levothyroxine-structure (Structure)

Chemical structure of levothyroxine sodium showing the iodinated phenol rings, amino group, carboxylate group with sodium ion, and associated water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.